This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Aug;4(8):630-40.

doi: 10.1038/nri1417.

HIV and SIV CTL escape: implications for vaccine design

Philip J R Goulder¹, David I Watkins

Affiliations

Affiliation

¹ Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, UK. philip.goulder@ndm.ox.ac.uk

PMID: 15286729
DOI: 10.1038/nri1417

Review

HIV and SIV CTL escape: implications for vaccine design

Philip J R Goulder et al. Nat Rev Immunol. 2004 Aug.

. 2004 Aug;4(8):630-40.

doi: 10.1038/nri1417.

Authors

Philip J R Goulder¹, David I Watkins

Affiliation

¹ Department of Paediatrics, Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, UK. philip.goulder@ndm.ox.ac.uk

PMID: 15286729
DOI: 10.1038/nri1417

No abstract available

PubMed Disclaimer

Similar articles

CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
Yang OO. Yang OO. Trends Immunol. 2004 Mar;25(3):138-42. doi: 10.1016/j.it.2004.01.004. Trends Immunol. 2004. PMID: 15036041 Review. No abstract available.
HIV CTL escape: at what cost?
Smith SM. Smith SM. Retrovirology. 2004 May 12;1:8. doi: 10.1186/1742-4690-1-8. Retrovirology. 2004. PMID: 15169568 Free PMC article.
AIDS. Escape from the immune system.
Walker BD, Goulder PJ. Walker BD, et al. Nature. 2000 Sep 21;407(6802):313-4. doi: 10.1038/35030283. Nature. 2000. PMID: 11014174 No abstract available.
New finding on immune response to HIV Tat may contribute to vaccine, treatment.
James JS. James JS. AIDS Treat News. 2000 Sep 22;(351):4. AIDS Treat News. 2000. PMID: 12173551
Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location.
Masopust D. Masopust D. J Intern Med. 2009 Jan;265(1):125-37. doi: 10.1111/j.1365-2796.2008.02054.x. J Intern Med. 2009. PMID: 19093965 Review.

See all similar articles

Cited by

Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
Iseda S, Takahashi N, Poplimont H, Nomura T, Seki S, Nakane T, Nakamura M, Shi S, Ishii H, Furukawa S, Harada S, Naruse TK, Kimura A, Matano T, Yamamoto H. Iseda S, et al. J Virol. 2016 Jun 24;90(14):6276-6290. doi: 10.1128/JVI.00557-16. Print 2016 Jul 15. J Virol. 2016. PMID: 27122584 Free PMC article.
Human immunodeficiency virus vaccine trials.
O'Connell RJ, Kim JH, Corey L, Michael NL. O'Connell RJ, et al. Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a007351. doi: 10.1101/cshperspect.a007351. Cold Spring Harb Perspect Med. 2012. PMID: 23209178 Free PMC article. Review.
Suppression of HIV Replication by CD8(+) Regulatory T-Cells in Elite Controllers.
Lu W, Chen S, Lai C, Lai M, Fang H, Dao H, Kang J, Fan J, Guo W, Fu L, Andrieu JM. Lu W, et al. Front Immunol. 2016 Apr 18;7:134. doi: 10.3389/fimmu.2016.00134. eCollection 2016. Front Immunol. 2016. PMID: 27148256 Free PMC article.
Evaluation of cynomolgus macaque (Macaca fascicularis) endogenous retrovirus expression following simian immunodeficiency virus infection.
Marsh AK, Willer DO, Skokovets O, Iwajomo OH, Chan JK, MacDonald KS. Marsh AK, et al. PLoS One. 2012;7(6):e40158. doi: 10.1371/journal.pone.0040158. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768246 Free PMC article.
Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?
Lee WS, Parsons MS, Kent SJ, Lichtfuss M. Lee WS, et al. Front Immunol. 2015 May 27;6:265. doi: 10.3389/fimmu.2015.00265. eCollection 2015. Front Immunol. 2015. PMID: 26074924 Free PMC article. Review. No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov